Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...

The death toll and economic damage associated with flu highlight its role as one of the most harmful viruses in history.

It's a common storytelling trope: the stubborn foe who is eventually revealed to be a much-needed friend. Biology has its own ...

A study from the University of Maryland, Baltimore County (UMBC), published in Nature Communications, reveals how ...

On Saturday, the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) National Veterinary ...

This marks the first known case of HPAI in cattle in Wisconsin. While dairy cattle in a total of 18 states have been infected since the start of the outbreak in March 2024, APHIS has seen cases in ...

Synthetic binders developer Aptamer Group has signed a licensing agreement with Alphazyme for the use of an Optimer binder in ...

Whole Genome Amplification (WGA) offers vast opportunities in personalized medicine, cancer research, and reproductive health ...

Rifampicin, the main treatment for TB, is losing ground against drug-resistant bacteria and dormant infections, underscoring the need for smarter combination strategies. Pairing rifampicin with the ...

The U.S. Food and Drug Administration has granted regular approval to treatment with Rubraca (rucaparib) for the treatment of ...